Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2020
Reduced Toxicity Conditioning for Nonmalignant Hematopoietic Cell TransplantsCristina F Contreras, Janel R Long-Boyle, Kristin A Shimano, et al.
Blood Advances|April 20, 2021
Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxisChristine S Higham, Griffin Collins, Kristin A Shimano, et al.
Oncotarget|October 30, 2016
Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumorsKieuhoa T Vo, Erin E Karski, Nicole M Nasholm, et al.
Transplantation and Cellular Therapy|June 29, 2024
Cyclophosphamide and Thiotepa Increases Risk of Transplant-Associated Thrombotic MicroangiopathyChristine S Higham, Kristin A Shimano, Sandhya Kharbanda, et al.
Pediatric Blood & Cancer|October 19, 2023
Busulfan and subsequent malignancy: An evidence-based risk assessmentJanel R Long-Boyle, Donald B Kohn, Ami J Shah, et al.
Transplantation and Cellular Therapy|December 9, 2025
Fludarabine Pharmacokinetic Model-Based Dosing Minimizes the Risk of Graft Rejection in Pediatric Patients Undergoing Allogeneic Hematopoietic Cell TransplantationChristopher C Dvorak, Ella Waters, William C Temple, et al.
Blood|March 5, 2026
Nonmyeloablative Conditioning Combined with Anti-CD117 Antibody Briquilimab in Older Adults with High-Risk AML and MDSLori S Muffly, Catherine J Lee, Arpita Gandhi, et al.
Transplantation and Cellular Therapy|February 12, 2025
Younger children with nonmalignant disease have increased incidence of mixed myeloid chimerism after allogeneic hematopoietic cell transplantation with busulfan-based conditioningChristopher C Dvorak, William C Temple, Gabriel Salinas Cisneros, et al.
Blood Advances|July 23, 2024
Effect of rabbit ATG PK on outcomes after TCR-αβ/CD19-depleted pediatric haploidentical HCT for hematologic malignancyChristopher C Dvorak, Janel R Long-Boyle, Lucia Holbrook-Brown, et al.
Transplantation and Cellular Therapy|April 4, 2025
High Melphalan Exposure Increases the Risk of Graft-Versus-Host Disease in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical TransplantationChristopher C Dvorak, Soohee Cho, Gabriel Salinas Cisneros, et al.
Pageof 3